{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:10:22Z","timestamp":1793315422818,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00134-024-07381-z","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T11:01:39Z","timestamp":1711623699000},"page":"526-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Challenges for a broad international implementation of the current severe community-acquired pneumonia guidelines"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8164-1453","authenticated-orcid":false,"given":"Jorge I. F.","family":"Salluh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"P\u00f3voa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abi","family":"Beane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Sendagire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pilcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Polverino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Estenssoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Frat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Nseir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandack","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Lisboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"7381_CR1","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger C, Blacker B, Khalil IA et al (2018) Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis 18:1191\u20131210. https:\/\/doi.org\/10.1016\/S1473-3099(18)30310-4","journal-title":"Lancet Infect Dis"},{"key":"7381_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B et al (2023) ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med 49:615\u2013632. https:\/\/doi.org\/10.1007\/s00134-023-07033-8","journal-title":"Intensive Care Med"},{"key":"7381_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/QCO.0000000000000713","volume":"34","author":"S Kerneis","year":"2021","unstructured":"Kerneis S, Visseaux B, Armand-Lefevre L, Timsit J-F (2021) Molecular diagnostic methods for pneumonia: how can they be applied in practice? Curr Opin Infect Dis 34:118\u2013125. https:\/\/doi.org\/10.1097\/QCO.0000000000000713","journal-title":"Curr Opin Infect Dis"},{"key":"7381_CR4","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1093\/cid\/ciaa508","volume":"71","author":"KE Hanson","year":"2020","unstructured":"Hanson KE, Azar MM, Banerjee R et al (2020) Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA\u2019s diagnostics committee. Clin Infect Dis 71:2744\u20132751. https:\/\/doi.org\/10.1093\/cid\/ciaa508","journal-title":"Clin Infect Dis"},{"key":"7381_CR5","doi-asserted-by":"publisher","unstructured":"Jain S, Self WH, Wunderink RG, et al (2015) Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. New Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1500245","DOI":"10.1056\/NEJMoa1500245"},{"key":"7381_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41579-021-00598-5","volume":"19","author":"IN Okeke","year":"2021","unstructured":"Okeke IN, Ihekweazu C (2021) The importance of molecular diagnostics for infectious diseases in low-resource settings. Nat Rev Microbiol 19:547\u2013548. https:\/\/doi.org\/10.1038\/s41579-021-00598-5","journal-title":"Nat Rev Microbiol"},{"key":"7381_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003622","volume":"5","author":"IN Okeke","year":"2020","unstructured":"Okeke IN, Feasey N, Parkhill J et al (2020) Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings. BMJ Glob Health 5:e003622. https:\/\/doi.org\/10.1136\/bmjgh-2020-003622","journal-title":"BMJ Glob Health"},{"key":"7381_CR8","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.cmi.2021.05.037","volume":"27","author":"C Lim","year":"2021","unstructured":"Lim C, Ashley EA, Hamers RL et al (2021) Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries. Clin Microbiol Infect 27:1391\u20131399. https:\/\/doi.org\/10.1016\/j.cmi.2021.05.037","journal-title":"Clin Microbiol Infect"},{"key":"7381_CR9","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1016\/S1473-3099(18)30093-8","volume":"18","author":"S Ombelet","year":"2018","unstructured":"Ombelet S, Ronat J-B, Walsh T et al (2018) Clinical bacteriology in low-resource settings: today\u2019s solutions. Lancet Infect Dis 18:e248\u2013e258. https:\/\/doi.org\/10.1016\/S1473-3099(18)30093-8","journal-title":"Lancet Infect Dis"},{"key":"7381_CR10","doi-asserted-by":"publisher","first-page":"1602426","DOI":"10.1183\/13993003.02426-2016","volume":"50","author":"B Rochwerg","year":"2017","unstructured":"Rochwerg B, Brochard L, Elliott MW et al (2017) Official ERS\/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 50:1602426. https:\/\/doi.org\/10.1183\/13993003.02426-2016","journal-title":"Eur Respir J"},{"key":"7381_CR11","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1001\/jama.2015.12402","volume":"314","author":"V Lemiale","year":"2015","unstructured":"Lemiale V, Mokart D, Resche-Rigon M et al (2015) Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA 314:1711. https:\/\/doi.org\/10.1001\/jama.2015.12402","journal-title":"JAMA"},{"key":"7381_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S2213-2600(22)00096-0","volume":"10","author":"R Coudroy","year":"2022","unstructured":"Coudroy R, Frat J-P, Ehrmann S et al (2022) High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial. Lancet Respir Med 10:641\u2013649. https:\/\/doi.org\/10.1016\/S2213-2600(22)00096-0","journal-title":"Lancet Respir Med"},{"key":"7381_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00134-023-06981-5","volume":"49","author":"YM Arabi","year":"2023","unstructured":"Arabi YM, Al-Dorzi HM, Aldekhyl S et al (2023) Long-term outcomes of patients with COVID-19 treated with helmet noninvasive ventilation or usual respiratory support: follow-up study of the Helmet-COVID randomized clinical trial. Intensive Care Med 49:302\u2013312. https:\/\/doi.org\/10.1007\/s00134-023-06981-5","journal-title":"Intensive Care Med"},{"key":"7381_CR14","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/jama.2021.4682","volume":"325","author":"DL Grieco","year":"2021","unstructured":"Grieco DL, Menga LS, Cesarano M et al (2021) Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: the HENIVOT randomized clinical trial. JAMA 325:1731. https:\/\/doi.org\/10.1001\/jama.2021.4682","journal-title":"JAMA"},{"key":"7381_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/jama.2022.0028","volume":"327","author":"GD Perkins","year":"2022","unstructured":"Perkins GD, Ji C, Connolly BA et al (2022) Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized clinical trial. JAMA 327:546. https:\/\/doi.org\/10.1001\/jama.2022.0028","journal-title":"JAMA"},{"key":"7381_CR16","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","volume":"372","author":"J-P Frat","year":"2015","unstructured":"Frat J-P, Thille AW, Mercat A et al (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372:2185\u20132196. https:\/\/doi.org\/10.1056\/NEJMoa1503326","journal-title":"N Engl J Med"},{"key":"7381_CR17","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1001\/jama.2018.14282","volume":"320","author":"E Azoulay","year":"2018","unstructured":"Azoulay E, Lemiale V, Mokart D et al (2018) Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial. JAMA 320:2099. https:\/\/doi.org\/10.1001\/jama.2018.14282","journal-title":"JAMA"},{"key":"7381_CR18","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1001\/jama.2022.15613","volume":"328","author":"J-P Frat","year":"2022","unstructured":"Frat J-P, Quenot J-P, Badie J et al (2022) Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: the SOHO-COVID randomized clinical trial. JAMA 328:1212. https:\/\/doi.org\/10.1001\/jama.2022.15613","journal-title":"JAMA"},{"key":"7381_CR19","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1001\/jama.2021.20714","volume":"326","author":"GA Ospina-Tasc\u00f3n","year":"2021","unstructured":"Ospina-Tasc\u00f3n GA, Calder\u00f3n-Tapia LE, Garc\u00eda AF et al (2021) Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients With severe COVID-19: a randomized clinical trial. JAMA 326:2161. https:\/\/doi.org\/10.1001\/jama.2021.20714","journal-title":"JAMA"},{"key":"7381_CR20","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200:e45\u2013e67. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST","journal-title":"Am J Respir Crit Care Med"},{"key":"7381_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/resp.13248","volume":"23","author":"G Waterer","year":"2018","unstructured":"Waterer G (2018) Empiric antibiotics for community-acquired pneumonia: a macrolide and a beta-lactam please! Respirology 23:450\u2013451. https:\/\/doi.org\/10.1111\/resp.13248","journal-title":"Respirology"},{"key":"7381_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13054-023-04466-x","volume":"27","author":"LF Reyes","year":"2023","unstructured":"Reyes LF, Garcia E, Ib\u00e1\u00f1ez-Prada ED et al (2023) Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis. Crit Care 27:212. https:\/\/doi.org\/10.1186\/s13054-023-04466-x","journal-title":"Crit Care"},{"key":"7381_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.rmed.2018.05.020","volume":"140","author":"FW Arnold","year":"2018","unstructured":"Arnold FW, Lopardo G, Wiemken TL et al (2018) Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia. Respir Med 140:115\u2013121. https:\/\/doi.org\/10.1016\/j.rmed.2018.05.020","journal-title":"Respir Med"},{"key":"7381_CR24","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"KS Ikuta","year":"2022","unstructured":"Ikuta KS, Swetschinski LR, Robles Aguilar G et al (2022) Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet 400:2221\u20132248. https:\/\/doi.org\/10.1016\/S0140-6736(22)02185-7","journal-title":"The Lancet"},{"key":"7381_CR25","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.chest.2020.07.089","volume":"158","author":"MW Pletz","year":"2020","unstructured":"Pletz MW, Blasi F, Chalmers JD et al (2020) International perspective on the new 2019 American Thoracic Society\/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline. Chest 158:1912\u20131918. https:\/\/doi.org\/10.1016\/j.chest.2020.07.089","journal-title":"Chest"},{"key":"7381_CR26","doi-asserted-by":"publisher","first-page":"00096","DOI":"10.1183\/23120541.00096-2018","volume":"4","author":"M Carugati","year":"2018","unstructured":"Carugati M, Aliberti S, Reyes LF et al (2018) Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study. ERJ Open Res 4:00096\u201302018. https:\/\/doi.org\/10.1183\/23120541.00096-2018","journal-title":"ERJ Open Res"},{"key":"7381_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/23744235.2017.1350881","volume":"50","author":"P Peyrani","year":"2018","unstructured":"Peyrani P, Wiemken TL, Metersky ML et al (2018) The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization. Infect Dis 50:13\u201320. https:\/\/doi.org\/10.1080\/23744235.2017.1350881","journal-title":"Infect Dis"},{"key":"7381_CR28","doi-asserted-by":"publisher","unstructured":"Pirracchio R, Annane D, Waschka AK, et al (2023) Patient-level meta-analysis of low-dose hydrocortisone in adults with septic shock. NEJM Evidence. https:\/\/doi.org\/10.1056\/EVIDoa2300034","DOI":"10.1056\/EVIDoa2300034"},{"key":"7381_CR29","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"P-F Dequin","year":"2023","unstructured":"Dequin P-F, Meziani F, Quenot J-P et al (2023) Hydrocortisone in severe community-acquired pneumonia. N Engl J Med 388:1931\u20131941. https:\/\/doi.org\/10.1056\/NEJMoa2215145","journal-title":"N Engl J Med"},{"key":"7381_CR30","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","volume":"48","author":"GU Meduri","year":"2022","unstructured":"Meduri GU, Shih M-C, Bridges L et al (2022) Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med 48:1009\u20131023. https:\/\/doi.org\/10.1007\/s00134-022-06684-3","journal-title":"Intensive Care Med"},{"key":"7381_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.7326\/M15-0715","volume":"163","author":"RAC Siemieniuk","year":"2015","unstructured":"Siemieniuk RAC, Meade MO, Alonso-Coello P et al (2015) Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis. Ann Intern Med 163:519\u2013528. https:\/\/doi.org\/10.7326\/M15-0715","journal-title":"Ann Intern Med"},{"key":"7381_CR32","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/CCM.0000000000004267","volume":"48","author":"N Arulkumaran","year":"2020","unstructured":"Arulkumaran N, Khpal M, Tam K et al (2020) Effect of antibiotic discontinuation strategies on mortality and infectious complications in critically Ill septic patients: a meta-analysis and trial sequential analysis*. Crit Care Med 48:757\u2013764. https:\/\/doi.org\/10.1097\/CCM.0000000000004267","journal-title":"Crit Care Med"},{"key":"7381_CR33","doi-asserted-by":"publisher","unstructured":"Jensen JU, Hein L, Lundgren B, et al (2011) Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial: Crit Care Med 39:2048\u20132058. https:\/\/doi.org\/10.1097\/CCM.0b013e31821e8791","DOI":"10.1097\/CCM.0b013e31821e8791"},{"key":"7381_CR34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/cid\/ciz545","volume":"70","author":"IS Kamat","year":"2020","unstructured":"Kamat IS, Ramachandran V, Eswaran H et al (2020) Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis. Clin Infect Dis 70:538\u2013542. https:\/\/doi.org\/10.1093\/cid\/ciz545","journal-title":"Clin Infect Dis"},{"key":"7381_CR35","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/CCM.0b013e31828e969f","volume":"41","author":"CF Oliveira","year":"2013","unstructured":"Oliveira CF, Botoni FA, Oliveira CRA et al (2013) Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial*. Crit Care Med 41:2336\u20132343. https:\/\/doi.org\/10.1097\/CCM.0b013e31828e969f","journal-title":"Crit Care Med"},{"key":"7381_CR36","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/cid\/cix179","volume":"64","author":"DC Chu","year":"2017","unstructured":"Chu DC, Mehta AB, Walkey AJ (2017) Practice patterns and outcomes associated with procalcitonin use in critically Ill patients with sepsis. Clin Infect Dis 64:1509\u20131515. https:\/\/doi.org\/10.1093\/cid\/cix179","journal-title":"Clin Infect Dis"},{"key":"7381_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/QCO.0000000000000357","volume":"30","author":"KA Cawcutt","year":"2017","unstructured":"Cawcutt KA, Fey PD, Kalil AC (2017) Respiratory pathogen panels in the hospital: good or unnecessary? Curr Opin Infect Dis 30:226\u2013230. https:\/\/doi.org\/10.1097\/QCO.0000000000000357","journal-title":"Curr Opin Infect Dis"},{"key":"7381_CR38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/MCC.0000000000000435","volume":"23","author":"K Cawcutt","year":"2017","unstructured":"Cawcutt K, Kalil AC (2017) Pneumonia with bacterial and viral coinfection. Curr Opin Crit Care 23:385\u2013390. https:\/\/doi.org\/10.1097\/MCC.0000000000000435","journal-title":"Curr Opin Crit Care"},{"key":"7381_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmi.2021.09.025","volume":"28","author":"E Gentilotti","year":"2022","unstructured":"Gentilotti E, De Nardo P, Cremonini E et al (2022) Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis. Clin Microbiol Infect 28:13\u201322. https:\/\/doi.org\/10.1016\/j.cmi.2021.09.025","journal-title":"Clin Microbiol Infect"},{"key":"7381_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/QCO.0000000000000148","volume":"28","author":"TL Basnayake","year":"2015","unstructured":"Basnayake TL, Waterer GW (2015) Rapid diagnostic tests for defining the cause of community-acquired pneumonia. Curr Opin Infect Dis 28:185\u2013192. https:\/\/doi.org\/10.1097\/QCO.0000000000000148","journal-title":"Curr Opin Infect Dis"},{"key":"7381_CR41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13054-019-2539-x","volume":"23","author":"AC Kalil","year":"2019","unstructured":"Kalil AC, Thomas PG (2019) Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care 23:258. https:\/\/doi.org\/10.1186\/s13054-019-2539-x","journal-title":"Crit Care"},{"key":"7381_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S2213-2600(22)00528-8","volume":"11","author":"A Amstutz","year":"2023","unstructured":"Amstutz A, Speich B, Mentr\u00e9 F et al (2023) Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet Respir Med 11:453\u2013464. https:\/\/doi.org\/10.1016\/S2213-2600(22)00528-8","journal-title":"Lancet Respir Med"},{"key":"7381_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/QCO.0000000000000819","volume":"35","author":"I Martin-Loeches","year":"2022","unstructured":"Martin-Loeches I, Garduno A, Povoa P, Nseir S (2022) Choosing antibiotic therapy for severe community-acquired pneumonia. Curr Opin Infect Dis 35:133\u2013139. https:\/\/doi.org\/10.1097\/QCO.0000000000000819","journal-title":"Curr Opin Infect Dis"},{"key":"7381_CR44","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society. Clin Infect Dis 63:e61\u2013e111. https:\/\/doi.org\/10.1093\/cid\/ciw353","journal-title":"Clin Infect Dis"},{"key":"7381_CR45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00134-022-06954-0","volume":"49","author":"L Kreitmann","year":"2023","unstructured":"Kreitmann L, Vasseur M, Jermoumi S et al (2023) Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study. Intensive Care Med 49:154\u2013165. https:\/\/doi.org\/10.1007\/s00134-022-06954-0","journal-title":"Intensive Care Med"},{"key":"7381_CR46","doi-asserted-by":"publisher","unstructured":"Tillotson G, Lodise T, Classi P, et al (2020) Antibiotic treatment failure and associated outcomes among adult patients with community-acquired pneumonia in the outpatient setting: a real-world US insurance claims database study. Open Forum Infect Dis 7:ofaa065. https:\/\/doi.org\/10.1093\/ofid\/ofaa065","DOI":"10.1093\/ofid\/ofaa065"},{"key":"7381_CR47","doi-asserted-by":"publisher","unstructured":"Webb BJ, Sorensen J, Mecham I, et al (2019) Antibiotic use and outcomes after implementation of the drug resistance in pneumonia score in ED patients with community-onset pneumonia. Chest 156:843\u2013851. https:\/\/doi.org\/10.1016\/j.chest.2019.04.093","DOI":"10.1016\/j.chest.2019.04.093"},{"key":"7381_CR48","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/cid\/ciy631","volume":"68","author":"T Maruyama","year":"2019","unstructured":"Maruyama T, Fujisawa T, Ishida T et al (2019) A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clin Infect Dis 68:1080\u20131088. https:\/\/doi.org\/10.1093\/cid\/ciy631","journal-title":"Clin Infect Dis"},{"key":"7381_CR49","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1513\/AnnalsATS.201709-728OC","volume":"15","author":"PK Lindenauer","year":"2018","unstructured":"Lindenauer PK, Strait KM, Grady JN et al (2018) Variation in the diagnosis of aspiration pneumonia and association with hospital pneumonia outcomes. Annals ATS 15:562\u2013569. https:\/\/doi.org\/10.1513\/AnnalsATS.201709-728OC","journal-title":"Annals ATS"},{"key":"7381_CR50","doi-asserted-by":"publisher","first-page":"L1047","DOI":"10.1152\/ajplung.00279.2015","volume":"309","author":"RP Dickson","year":"2015","unstructured":"Dickson RP, Erb-Downward JR, Huffnagle GB (2015) Homeostasis and its disruption in the lung microbiome. Am J Physiol Lung Cell Mol Physiol 309:L1047\u2013L1055. https:\/\/doi.org\/10.1152\/ajplung.00279.2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"7381_CR51","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.2147\/CIA.S150499","volume":"12","author":"S Noguchi","year":"2017","unstructured":"Noguchi S, Yatera K, Kato T et al (2017) Impact of the number of aspiration risk factors on mortality and recurrence in community-onset pneumonia. CIA 12:2087\u20132094. https:\/\/doi.org\/10.2147\/CIA.S150499","journal-title":"CIA"},{"key":"7381_CR52","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1097\/HJH.0b013e328357a87a","volume":"30","author":"C-L Liu","year":"2012","unstructured":"Liu C-L, Shau W-Y, Wu C-S, Lai M-S (2012) Angiotensin-converting enzyme inhibitor\/angiotensin II receptor blockers and pneumonia risk among stroke patients. J Hypertens 30:2223\u20132229. https:\/\/doi.org\/10.1097\/HJH.0b013e328357a87a","journal-title":"J Hypertens"},{"key":"7381_CR53","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/resp.12590","volume":"20","author":"HW Lee","year":"2015","unstructured":"Lee HW, Min J, Park J et al (2015) Clinical impact of early bronchoscopy in mechanically ventilated patients with aspiration pneumonia. Respirology 20:1115\u20131122. https:\/\/doi.org\/10.1111\/resp.12590","journal-title":"Respirology"},{"key":"7381_CR54","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1056\/NEJMra1714562","volume":"380","author":"LA Mandell","year":"2019","unstructured":"Mandell LA, Niederman MS (2019) Aspiration pneumonia. N Engl J Med 380:651\u2013663. https:\/\/doi.org\/10.1056\/NEJMra1714562","journal-title":"N Engl J Med"},{"key":"7381_CR55","unstructured":"Cabana MD, Rand CS, Powe NR, et al (2024) Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement"},{"key":"7381_CR56","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00134-022-06956-y","volume":"49","author":"P P\u00f3voa","year":"2023","unstructured":"P\u00f3voa P, Coelho L, Dal-Pizzol F et al (2023) How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med 49:142\u2013153. https:\/\/doi.org\/10.1007\/s00134-022-06956-y","journal-title":"Intensive Care Med"},{"key":"7381_CR57","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.ccc.2022.06.010","volume":"38","author":"MF Mart","year":"2022","unstructured":"Mart MF, Sendagire C, Ely EW et al (2022) Oxygen as an essential medicine. Crit Care Clin 38:795\u2013808. https:\/\/doi.org\/10.1016\/j.ccc.2022.06.010","journal-title":"Crit Care Clin"},{"key":"7381_CR58","doi-asserted-by":"publisher","unstructured":"Rabello L, Concei\u00e7\u00e3o C, Ebecken K, et al (2015) Management of severe community-acquired pneumonia in Brazil: a secondary analysis of an international survey. Revista Brasileira de Terapia Intensiva. https:\/\/doi.org\/10.5935\/0103-507X.20150010","DOI":"10.5935\/0103-507X.20150010"},{"key":"7381_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001675","volume":"4","author":"HC Turner","year":"2019","unstructured":"Turner HC, Hao NV, Yacoub S et al (2019) Achieving affordable critical care in low-income and middle-income countries. BMJ Glob Health 4:e001675. https:\/\/doi.org\/10.1136\/bmjgh-2019-001675","journal-title":"BMJ Glob Health"},{"key":"7381_CR60","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13756-020-00871-x","volume":"10","author":"YR Saharman","year":"2021","unstructured":"Saharman YR, Karuniawati A, Severin JA, Verbrugh HA (2021) Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review. Antimicrob Resist Infect Control 10:22. https:\/\/doi.org\/10.1186\/s13756-020-00871-x","journal-title":"Antimicrob Resist Infect Control"},{"key":"7381_CR61","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.1173","volume":"3","author":"JP Cimiotti","year":"2022","unstructured":"Cimiotti JP, Becker ER, Li Y et al (2022) Association of registered nurse staffing with mortality risk of medicare beneficiaries hospitalized with sepsis. JAMA Health Forum 3:e221173. https:\/\/doi.org\/10.1001\/jamahealthforum.2022.1173","journal-title":"JAMA Health Forum"},{"key":"7381_CR62","doi-asserted-by":"publisher","unstructured":"Pickens CI, Gao CA, Bodner J, et al (2023) An adjudication protocol for severe pneumonia. Open Forum Infect Dis 10:ofad336. https:\/\/doi.org\/10.1093\/ofid\/ofad336","DOI":"10.1093\/ofid\/ofad336"},{"key":"7381_CR63","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00134-019-05519-y","volume":"45","author":"A Torres","year":"2019","unstructured":"Torres A, Chalmers JD, Dela Cruz CS et al (2019) Challenges in severe community-acquired pneumonia: a point-of-view review. Intensive Care Med 45:159\u2013171. https:\/\/doi.org\/10.1007\/s00134-019-05519-y","journal-title":"Intensive Care Med"},{"key":"7381_CR64","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ccm.2022.04.003","volume":"43","author":"CI Pickens","year":"2022","unstructured":"Pickens CI, Wunderink RG (2022) Novel and rapid diagnostics for common infections in the critically Ill patient. Clin Chest Med 43:401\u2013410. https:\/\/doi.org\/10.1016\/j.ccm.2022.04.003","journal-title":"Clin Chest Med"},{"key":"7381_CR65","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s13054-020-03114-y","volume":"24","author":"C Monard","year":"2020","unstructured":"Monard C, Pehlivan J, Auger G et al (2020) Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia. Crit Care 24:434. https:\/\/doi.org\/10.1186\/s13054-020-03114-y","journal-title":"Crit Care"},{"key":"7381_CR66","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ijid.2016.02.878","volume":"45","author":"L Sharon","year":"2016","unstructured":"Sharon L, Baliga S, Shah J et al (2016) Fluorescent In Situ Hybridization (FISH) for the detection and differentiation of mycobacterium tuberculosis and NTM in sputum and culture. Int J Infect Dis 45:411. https:\/\/doi.org\/10.1016\/j.ijid.2016.02.878","journal-title":"Int J Infect Dis"},{"key":"7381_CR67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jinf.2018.11.005","volume":"79","author":"T Pan","year":"2019","unstructured":"Pan T, Tan R, Qu H et al (2019) Next-generation sequencing of the BALF in the diagnosis of community-acquired pneumonia in immunocompromised patients. J Infect 79:61\u201374. https:\/\/doi.org\/10.1016\/j.jinf.2018.11.005","journal-title":"J Infect"},{"key":"7381_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217508","volume":"14","author":"IM Zacharioudakis","year":"2019","unstructured":"Zacharioudakis IM, Zervou FN, Shehadeh F, Mylonakis E (2019) Cost-effectiveness of molecular diagnostic assays for the therapy of severe sepsis and septic shock in the emergency department. PLoS ONE 14:e0217508. https:\/\/doi.org\/10.1371\/journal.pone.0217508","journal-title":"PLoS ONE"},{"key":"7381_CR69","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1590\/S0103-507X2011000400016","volume":"23","author":"LSCF Rabello","year":"2011","unstructured":"Rabello LSCF, Pitrowsky MT, Soares M et al (2011) Novel biomarkers in severe community-acquired pneumonia. Revista Brasileira de terapia intensiva 23:499\u2013506","journal-title":"Revista Brasileira de terapia intensiva"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07381-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-024-07381-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07381-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T08:03:37Z","timestamp":1713168217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-024-07381-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["7381"],"URL":"https:\/\/doi.org\/10.1007\/s00134-024-07381-z","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}